Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AXOTAN Aktiebolag
AB
Active
Org 5564341047
Rydebäck
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1991
6 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AXOTAN Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
HR
Hans Robert Jonsson
Audit
Audit
2025
OP
Otto Peter Sixten Hermansson
Chief Executive Officer
Chief Executive Officer
2026
Former (1)
CL
Claes Lennart Grundström
Audit
Audit
2022 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
AP
Axel Peter Hermansson
Deputy Board Member
2022
KI
Karl-Johan Ingvar Öhman
Board of Directors
2026
MK
Maria Kristina Lundman Hedberg
Board of Directors
2026
JD
John David Wennerström
Chairman
2026
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Sikla AB
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AXOTAN Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network